CD19-BAFF Targeted CAR T-cells Clinical Trials
2 recruitingBiologic
Early Phase 12
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
CD19-BAFF CAR-T Cells Therapy for Patients With Relapsed / Refractory B-cell ALL and B-cell NHL
Acute Lymphoblastic Leukemia,B-CellNon-hodgkin Lymphoma,B Cell
Zhejiang University20 enrolled1 locationNCT06346912
Recruiting
Early Phase 1
CD19-BAFF CAR-T Cells Therapy for Patients With Autoimmune Diseases
Autoimmune Diseases
Zhejiang University45 enrolled1 locationNCT06279923